Assure Holdings Corp. (IONM)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -2.19 Million USD | 47.94% |
| 2022 | -4.21 Million USD | -128.33% |
| 2021 | 14.87 Million USD | 438.97% |
| 2020 | -4.38 Million USD | -134.36% |
| 2019 | 12.77 Million USD | 13.4% |
| 2018 | 11.26 Million USD | -14.54% |
| 2017 | 13.17 Million USD | 150.69% |
| 2016 | 5.25 Million USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | -100.0% |
| 2009 | 308.47 USD | -69.38% |
| 2008 | 1007.40 USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -466 Thousand USD | -10.43% |
| 2024 Q2 | -228 Thousand USD | 51.07% |
| 2023 Q3 | -574 Thousand USD | 69.12% |
| 2023 FY | -2.19 Million USD | 47.94% |
| 2023 Q1 | 179 Thousand USD | 103.44% |
| 2023 Q2 | -1.85 Million USD | -1138.55% |
| 2023 Q4 | -422 Thousand USD | 26.48% |
| 2022 Q2 | -2.35 Million USD | -386.04% |
| 2022 Q3 | -451 Thousand USD | 80.87% |
| 2022 Q4 | -5.2 Million USD | -1052.99% |
| 2022 Q1 | 824 Thousand USD | -84.44% |
| 2022 FY | -4.21 Million USD | -128.33% |
| 2021 Q4 | 5.29 Million USD | 23.42% |
| 2021 Q2 | 3.05 Million USD | 36.68% |
| 2021 Q3 | 4.29 Million USD | 40.63% |
| 2021 FY | 14.87 Million USD | 438.97% |
| 2021 Q1 | 2.23 Million USD | -28.29% |
| 2020 Q2 | -11.77 Million USD | -563.22% |
| 2020 Q4 | 3.11 Million USD | 79.9% |
| 2020 FY | -4.38 Million USD | -134.36% |
| 2020 Q1 | 2.54 Million USD | 149.38% |
| 2020 Q3 | 1.73 Million USD | 114.7% |
| 2019 Q3 | 6.67 Million USD | 0.47% |
| 2019 Q4 | -5.14 Million USD | -177.11% |
| 2019 FY | 12.77 Million USD | 13.4% |
| 2019 Q1 | 4.59 Million USD | 237.97% |
| 2019 Q2 | 6.64 Million USD | 44.54% |
| 2018 Q1 | 4.76 Million USD | 155.53% |
| 2018 FY | 11.26 Million USD | -14.54% |
| 2018 Q4 | -3.33 Million USD | -168.28% |
| 2018 Q3 | 4.87 Million USD | -1.45% |
| 2018 Q2 | 4.95 Million USD | 3.96% |
| 2017 Q3 | 7.03 Million USD | 106.98% |
| 2017 Q4 | -8.57 Million USD | -221.94% |
| 2017 Q1 | 3.38 Million USD | 7.09% |
| 2017 FY | 13.17 Million USD | 150.69% |
| 2017 Q2 | 3.39 Million USD | 0.49% |
| 2016 Q4 | 3.15 Million USD | -3.13% |
| 2016 Q1 | -512.00 USD | 0.0% |
| 2016 FY | 5.25 Million USD | 0.0% |
| 2016 Q2 | 692.55 Thousand USD | 135364.84% |
| 2016 Q3 | 3.25 Million USD | 370.6% |
| 2015 Q3 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 FY | - USD | -100.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | -100.0% |
| 2009 FY | 308.47 USD | -69.38% |
| 2009 Q4 | 6.29 USD | 0.0% |
| 2009 Q3 | - USD | -100.0% |
| 2009 Q2 | 100.78 USD | -38.23% |
| 2009 Q1 | 163.14 USD | -57.61% |
| 2008 FY | 1007.40 USD | 0.0% |
| 2008 Q3 | 600.79 USD | 2558.64% |
| 2008 Q2 | 22.60 USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q4 | 384.87 USD | -35.94% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 682.6 Million USD | 100.321% |
| Addus HomeCare Corporation | 339.87 Million USD | 100.646% |
| AirSculpt Technologies, Inc. | 121.9 Million USD | 101.8% |
| Amedisys, Inc. | 457.07 Million USD | 100.48% |
| American Oncology Network, Inc. | 66.05 Million USD | 103.321% |
| Astrana Health, Inc. | 214.95 Million USD | 101.021% |
| Aveanna Healthcare Holdings Inc. | 595.43 Million USD | 100.368% |
| IMAC Holdings, Inc. | 3.84 Million USD | 157.007% |
| biote Corp. | 127.48 Million USD | 101.721% |
| Cryo-Cell International, Inc. | 22.9 Million USD | 109.58% |
| Cross Country Healthcare, Inc. | 432.06 Million USD | 100.508% |
| COMPASS Pathways plc | -242.93 Thousand USD | -803.111% |
| DocGo Inc. | 178.95 Million USD | 101.226% |
| The Ensign Group, Inc. | 590.75 Million USD | 100.371% |
| Healthcare Services Group, Inc. | 251.45 Million USD | 100.873% |
| InnovAge Holding Corp. | 132.06 Million USD | 101.661% |
| The Joint Corp. | 107.14 Million USD | 102.048% |
| LifeStance Health Group, Inc. | 302.09 Million USD | 100.726% |
| Mobile-health Network Solutions Class A Ordinary Shares | -1.07 Million USD | -104.732% |
| ModivCare Inc. | 446.95 Million USD | 100.491% |
| NewGenIvf Group Limited | 1.68 Million USD | 230.457% |
| Novo Integrated Sciences, Inc. | 4.95 Million USD | 144.299% |
| Option Care Health, Inc. | 981.22 Million USD | 100.224% |
| P3 Health Partners Inc. | 31.63 Million USD | 106.935% |
| P3 Health Partners Inc. | 31.63 Million USD | 106.935% |
| The Pennant Group, Inc. | 61.9 Million USD | 103.544% |
| Surgery Partners, Inc. | 529.4 Million USD | 100.414% |
| Syra Health Corp. Class A Common Stock | 1.41 Million USD | 255.393% |
| Talkspace, Inc. | 74.38 Million USD | 102.95% |
| Talkspace, Inc. | 74.38 Million USD | 102.95% |
| The Oncology Institute, Inc. | 59.57 Million USD | 103.683% |
| The Oncology Institute, Inc. | 59.57 Million USD | 103.683% |